With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm
The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.Read More
Ether falls 7% following a multimillion dollar hack of a decentralized finance protocol
The Ethereum-linked token briefly fell below its critical $3,600 level as investors wrung their hands over several bearish events.
Palantir tops estimates, boosts fourth-quarter guidance on AI adoption
Palantir’s earnings topped third-quarter results and the company issued strong guidance, attributing much of its rapid growth to artificial intelligence.
Ormat Technologies Reports Third Quarter 2025 Financial Results
STRATEGIC PORTFOLIO EXPANSION AND STRONG PRODUCT SEGMENT PERFORMANCE DROVE REVENUE AND EARNINGS GROWTH HIGHLIGHTS REVENUE AND NET INCOME ATTRIBUTABLE TO THE COMPANY’S STOCKHOLDERS GREW 17.9% AND 9.3%, RESPECTIVELY ORMAT AND SLB PARTNER TO ACCELERATE AND EXPAND ENHANCED GEOTHERMAL SYSTEM DEVELOPMENT COMPANY INCREASES ITS FULL YEAR REVENUE AND EBITDA GUIDANCE RENO, Nev., Nov. 03, 2025 (GLOBE […]
Intel, AMD CPU prices rise due to AI demand: report
Post ContentRead More
Nasdaq, S&P holds onto gains as big tech rallies despite drop in manufacturing index
Post ContentRead More
VivoPower enters heads of agreement with KOSDAQ listed KWeather
Post ContentRead More
PSEG narrows 2025 earnings guidance to $4–$4.06 per share as capital investments advance and supply-demand risks persist
Post ContentRead More
L.B. Foster projects 25% Q4 sales growth and 115% EBITDA expansion amid record backlog
Post ContentRead More
Kenvue Non-GAAP EPS of $0.28, revenue of $3.76B
Post ContentRead More